Literature DB >> 12195020

Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis.

Jae Myun Lee1, Kyoung-Ho Lee, Magdalena Weidner, Barbara A Osborne, S Diane Hayward.   

Abstract

Epstein-Barr virus infection in vitro immortalizes primary B cells. EBNA2 is an Epstein-Barr virus-encoded transcriptional transactivator that mimics the effects of activated Notch signaling and is essential for this proliferative response. An assay using Sindbis virus (SV) as a cell death inducer revealed that, like Notch, EBNA2 also has antiapoptotic activity. We show that Nur77 is a mediator of SV-induced cell death and that EBNA2 antiapoptotic activity results from interaction with Nur77. EBNA2 colocalized with Nur77 in transfected cells and coprecipitated with Nur77 in IB4 B cells. EBNA2 binds to Nur77 through sequences in the EBNA2 amino acid 123-147 conserved domain and an EBNA2 mutant unable to bind Nur77 also lost the ability to protect cells from SV-induced apoptosis. EBNA2 exerted its antideath function by retaining Nur77 in the nucleus and preventing Nur77 from targeting mitochondria in response to apoptotic stimuli. Thus, targeting of Nur77 can be added to the list of strategies used by viruses to counter apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195020      PMCID: PMC129362          DOI: 10.1073/pnas.182552499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  71 in total

1.  Primary central nervous system malignant non-Hodgkin's lymphomas from HIV-infected and non-infected patients: expression of cellular surface proteins and Epstein-Barr viral markers.

Authors:  I Auperin; J Mikolt; E Oksenhendler; J B Thiebaut; M Brunet; B Dupont; F Morinet
Journal:  Neuropathol Appl Neurobiol       Date:  1994-06       Impact factor: 8.090

2.  Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas.

Authors:  J D Woronicz; B Calnan; V Ngo; A Winoto
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

3.  Recognition sequence of a highly conserved DNA binding protein RBP-J kappa.

Authors:  T Tun; Y Hamaguchi; N Matsunami; T Furukawa; T Honjo; M Kawaichi
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

4.  EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.

Authors:  P D Ling; J J Hsieh; I K Ruf; D R Rawlins; S D Hayward
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77.

Authors:  Z G Liu; S W Smith; K A McLaughlin; L M Schwartz; B A Osborne
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

6.  Induction of early response genes by cross-linking membrane Ig on B lymphocytes.

Authors:  P R Mittelstadt; A L DeFranco
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

7.  EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.

Authors:  P D Ling; J J Ryon; S D Hayward
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders.

Authors:  H Cen; P A Williams; H P McWilliams; M C Breinig; M Ho; J L McKnight
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113

9.  EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

Authors:  A J Sinclair; I Palmero; G Peters; P J Farrell
Journal:  EMBO J       Date:  1994-07-15       Impact factor: 11.598

10.  B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2.

Authors:  B Kempkes; D Spitkovsky; P Jansen-Dürr; J W Ellwart; E Kremmer; H J Delecluse; C Rottenberger; G W Bornkamm; W Hammerschmidt
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

View more
  36 in total

1.  CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation.

Authors:  Bogaslaw Kwiatkowski; Szu Yu Jenny Chen; William H Schubach
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli.

Authors:  Jae Myun Lee; Kyoung-Ho Lee; Christopher J Farrell; Paul D Ling; Bettina Kempkes; Jeon Han Park; S Diane Hayward
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent.

Authors:  Sabine Maier; Maja Santak; Anja Mantik; Kristina Grabusic; Elisabeth Kremmer; Wolfgang Hammerschmidt; Bettina Kempkes
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Epstein-Barr virus and virus human protein interaction maps.

Authors:  Michael A Calderwood; Kavitha Venkatesan; Li Xing; Michael R Chase; Alexei Vazquez; Amy M Holthaus; Alexandra E Ewence; Ning Li; Tomoko Hirozane-Kishikawa; David E Hill; Marc Vidal; Elliott Kieff; Eric Johannsen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-19       Impact factor: 11.205

Review 5.  Minireview: Nuclear receptors, hematopoiesis, and stem cells.

Authors:  John P Chute; Joel R Ross; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-24

6.  Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.

Authors:  Pamela M Pegman; Sinéad M Smith; Brendan N D'Souza; Sinéad T Loughran; Sabine Maier; Bettina Kempkes; Paul A Cahill; Matthew J Simmons; Céline Gélinas; Dermot Walls
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

7.  The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes.

Authors:  Richard N Hanna; Leo M Carlin; Harper G Hubbeling; Dominika Nackiewicz; Angela M Green; Jennifer A Punt; Frederic Geissmann; Catherine C Hedrick
Journal:  Nat Immunol       Date:  2011-07-03       Impact factor: 25.606

8.  Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.

Authors:  Eva M Campion; Roya Hakimjavadi; Sinéad T Loughran; Susan Phelan; Sinéad M Smith; Brendan N D'Souza; Rosemary J Tierney; Andrew I Bell; Paul A Cahill; Dermot Walls
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

9.  Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.

Authors:  Christopher J Farrell; Jae Myun Lee; Eui-Cheol Shin; Marek Cebrat; Philip A Cole; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

10.  Control of Rta expression critically determines transcription of viral and cellular genes following gammaherpesvirus infection.

Authors:  James R Hair; Paul A Lyons; Kenneth G C Smith; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.